Susquehanna Fundamental Investments’s Procept Biorobotics PRCT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$452K	Buy	+20,000	New	+$501K	0.01%	579

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Susquehanna Fundamental Investments's PRCT Position: Q2 2026 in Review

Susquehanna Fundamental Investments opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 20,000 shares worth $452K. The stake represents 0.01% of the portfolio and ranks #579 among its holdings.

254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Susquehanna Fundamental Investments held 20,000 shares of Procept Biorobotics worth $452K as of Q2 2026.
Procept Biorobotics was a new Susquehanna Fundamental Investments position in Q2 2026.
Procept Biorobotics made up 0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2026, its #579 holding.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2026, filed 14 Aug 2026.